Globally, GBS is an important cause of neonatal morbidity and mortality. GBS has recently been linked to adverse pregnancy outcomes. The potential interactions between GBS and the vaginal microbiome composition remain poorly understood. In addition, little is known about the vaginal microbiota of ...
Screening is performed at 35–39 weeks of pregnancy using a vaginal/rectal swab that is incubated in selective media such as Lim broth overnight and then sub-cultured for any colonies of β streptococci. The CAMP test can be used to differentiate GBS from β streptococci due to the ...
Group B streptococcus (GBS) is a bacterium commonly found in the vaginal flora and is usually of no consequence to women. However, vertical transmission of GBS to the baby during pregnancy and/or birth can lead to GBS-associated disease, a leading cause of neonatal morbidity and mortality in...